ISSCR Annual Meeting 2024

Be there when the brightest minds in stem cell research gather in Hamburg!

The Event

Networkers at heart

We would like to shape Life Science’s future – out of Northern Germany

About us
Nach unten
Moving forward, the Omics Hub will continue to serve as a key resource for clinicians and clinical network partners in order to drive novel research and ultimately improve personalized oncology and the treatment of patients.
Moving forward, the Omics Hub will continue to serve as a key resource for clinicians and clinical network partners in order to drive novel research and ultimately improve personalized oncology and the treatment of patients. (Image: Screenshot/Discover Oncology)

Indivumed: New Publication in Discover Oncology

Indivumed GmbH announced the fourth research publication enabled by the Indivumed Omics Hub. An interface for members of the Indivumed Global Clinical Network, the Omics ...

Read more …
Hans Kuhn hands over responsibilities to his successors Mariela Aranda (left) and Julianna Shibao (right).
Hans Kuhn hands over responsibilities to his successors Mariela Aranda (left) and Julianna Shibao (right). (Picture: altona Diagnostics)

New management at altona Diagnostics in Argentina and Brazil

After more than six years at the helm of the Argentine and Brazilian subsidiaries of altona Diagnostics based in Buenos ...

Read more …
3D vector field of the collagen direction and degree of orientation obtained by SAXS-Tensor-Tomography (Picture: DESY)
3D vector field of the collagen direction and degree of orientation obtained by SAXS-Tensor-Tomography (Picture: DESY)

Deeper Insights in Breast Cancer Metastasis

A collaborative effort between researchers from DESY, the University Medical Center Hamburg-Eppendorf (UKE), ...

Read more …

SurgMark: FDA 510(k) Clearance for SchurSign Tissue Marker

In January SurgMark GmbH announced that the U.S. Food & Drug Administration (FDA) has issued a 510(k) premarket notification for ...

Read more …

Synchron Acquires Equity Stake in ACQUANDAS

Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in patients with motor impairment, today announced the acquisition of an equity stake ...

Read more …

"Stealth Effect"

An experiment led by a team of DESY and Universität Hamburg scientists has discovered that gold nanoparticles can move through liquid ...

Read more …